DK0703980T3 - Intracellulære bindingsproteiner og anvendelser deraf - Google Patents

Intracellulære bindingsproteiner og anvendelser deraf

Info

Publication number
DK0703980T3
DK0703980T3 DK94919711T DK94919711T DK0703980T3 DK 0703980 T3 DK0703980 T3 DK 0703980T3 DK 94919711 T DK94919711 T DK 94919711T DK 94919711 T DK94919711 T DK 94919711T DK 0703980 T3 DK0703980 T3 DK 0703980T3
Authority
DK
Denmark
Prior art keywords
pct
binding proteins
date dec
applications
intracellular binding
Prior art date
Application number
DK94919711T
Other languages
Danish (da)
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0703980T3 publication Critical patent/DK0703980T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94919711T 1993-06-16 1994-06-15 Intracellulære bindingsproteiner og anvendelser deraf DK0703980T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307241A FR2706486B1 (fr) 1993-06-16 1993-06-16 Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
PCT/FR1994/000714 WO1994029446A2 (fr) 1993-06-16 1994-06-15 Proteines intracellulaires de liaison (pil) et leurs utilisations

Publications (1)

Publication Number Publication Date
DK0703980T3 true DK0703980T3 (da) 2003-05-19

Family

ID=9448183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919711T DK0703980T3 (da) 1993-06-16 1994-06-15 Intracellulære bindingsproteiner og anvendelser deraf

Country Status (24)

Country Link
US (1) US6159947A (xx)
EP (1) EP0703980B1 (xx)
JP (1) JP4384260B2 (xx)
KR (1) KR100342233B1 (xx)
CN (1) CN1076052C (xx)
AT (1) ATE231916T1 (xx)
AU (1) AU7076394A (xx)
BR (1) BR9407512A (xx)
CA (1) CA2165458C (xx)
CZ (1) CZ289039B6 (xx)
DE (1) DE69432075T2 (xx)
DK (1) DK0703980T3 (xx)
ES (1) ES2191031T3 (xx)
FI (1) FI120311B (xx)
FR (1) FR2706486B1 (xx)
HU (1) HU219138B (xx)
NO (1) NO319466B1 (xx)
NZ (1) NZ268038A (xx)
PL (1) PL180760B1 (xx)
RU (1) RU2218400C2 (xx)
SK (1) SK285169B6 (xx)
UA (1) UA46709C2 (xx)
WO (1) WO1994029446A2 (xx)
ZA (1) ZA944303B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003342B1 (en) 1990-04-18 2011-08-23 Board Of Regents, The University Of Texas System Method for identifying farnesyl transferase inhibitors
US6790633B1 (en) * 1990-04-18 2004-09-14 Michael S. Brown Method of inhibiting a farnesyl transferase enzyme
FR2724320B1 (fr) 1994-09-13 1996-12-20 Transgene Sa Nouvel implant pour le traitement des maladies acquises
US5518042A (en) * 1994-09-16 1996-05-21 Huyck Licensco, Inc. Papermaker's forming fabric with additional cross machine direction locator and fiber supporting yarns
FR2738151B1 (fr) * 1995-09-04 1997-09-26 Rhone Poulenc Rorer Sa Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
IL129986A0 (en) 1996-12-06 2000-02-29 Rhone Poulenc Rorer Pharma Polypeptides encoded by a human lipase-like gene compositions and methods
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
FR2758569B1 (fr) * 1997-01-20 1999-04-02 Centre Nat Rech Scient Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
AU3604800A (en) * 1999-02-26 2000-09-14 Mindset Biopharmaceuticals (Usa) Ltd. Method for regulating the stability of recombinant proteins, and antibodies and products useful therein
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
IL151987A0 (en) 2000-03-31 2003-04-10 Aventis Pharma Inc Nuclear factor kb inducing factor
US20030104402A1 (en) * 2001-01-23 2003-06-05 University Of Rochester Methods of producing or identifying intrabodies in eukaryotic cells
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
KR101602876B1 (ko) 2014-07-22 2016-03-11 아주대학교산학협력단 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용
KR101602870B1 (ko) 2014-07-22 2016-03-21 아주대학교산학협력단 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용
BR122020006907B8 (pt) * 2014-10-23 2023-01-31 Singh Biotechnology Llc Anticorpo de domínio único anti-kras e seu uso, métodos in vitro para medir os níveis do referido anticorpo e para diagnosticar um distúrbio mediado por um componente intracelular, polipetídeo isolado e composição compreendendo o referido anticorpo ou polipeptídeo isolado
US20180072815A1 (en) 2014-10-23 2018-03-15 Singh Biotechnology, Llc Single Domain Antibodies Directed Against Intracellular Antigens
TWI746473B (zh) 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 針對細胞內抗原之單域抗體
CA3025757A1 (en) 2016-05-27 2017-11-30 Orum Therapeutics Inc. Cytosol-penetrating antibody and use thereof
WO2019244086A1 (en) 2018-06-21 2019-12-26 Orum Therapeutics Inc. Cell/tissue-specific cell-penetrating antibodies
CN110981943B (zh) * 2019-12-02 2021-08-03 清华大学 多肽及其在制备药物中的用途和药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE3915952A1 (de) * 1989-05-12 1990-12-06 Peter Werner Wirkstoff/medikament/biotechnologisches verfahren zur behandlung von erkrankungen, die mit exo- oder endogenen intrazellulaeren proteinen (onkogene etc.) assoziert sind
EP0556197A4 (en) * 1990-09-25 1994-05-18 Univ Connecticut Prolonging expression of polynucleotides introduced into a cell
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
JP3512795B2 (ja) * 1991-09-30 2004-03-31 アメリカ合衆国 組換免疫毒素
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
PT651805E (pt) * 1992-07-17 2007-02-28 Dana Farber Cancer Inst Inc Método de ligação intracelular de moléculas-alvo

Also Published As

Publication number Publication date
CN1126491A (zh) 1996-07-10
EP0703980A1 (fr) 1996-04-03
AU7076394A (en) 1995-01-03
CA2165458A1 (fr) 1994-12-22
CZ329595A3 (en) 1996-03-13
KR100342233B1 (ko) 2002-12-05
DE69432075T2 (de) 2003-09-04
BR9407512A (pt) 1997-01-07
CA2165458C (fr) 2011-05-10
ATE231916T1 (de) 2003-02-15
CZ289039B6 (cs) 2001-10-17
EP0703980B1 (fr) 2003-01-29
HU9503615D0 (en) 1996-02-28
FI956057A0 (fi) 1995-12-15
HU219138B (hu) 2001-02-28
SK156895A3 (en) 1996-05-08
RU2218400C2 (ru) 2003-12-10
DE69432075D1 (de) 2003-03-06
JPH08511162A (ja) 1996-11-26
WO1994029446A3 (fr) 1995-02-02
NZ268038A (en) 1997-12-19
FI120311B (fi) 2009-09-15
PL312213A1 (en) 1996-04-01
NO955011D0 (no) 1995-12-11
US6159947A (en) 2000-12-12
JP4384260B2 (ja) 2009-12-16
CN1076052C (zh) 2001-12-12
NO319466B1 (no) 2005-08-15
ES2191031T3 (es) 2003-09-01
FI956057A (fi) 1995-12-15
HUT74266A (en) 1996-11-28
UA46709C2 (uk) 2002-06-17
SK285169B6 (sk) 2006-07-07
WO1994029446A2 (fr) 1994-12-22
FR2706486B1 (fr) 1995-09-01
FR2706486A1 (fr) 1994-12-23
NO955011L (no) 1995-12-11
PL180760B1 (pl) 2001-04-30
ZA944303B (en) 1995-02-14

Similar Documents

Publication Publication Date Title
DK0703980T3 (da) Intracellulære bindingsproteiner og anvendelser deraf
ATE400651T1 (de) Verwendung von grünem fluoreszenzprotein
FI934811A0 (fi) Stabiliserade enzymer och detergentfoereningar
ATE348175T1 (de) Method eder intrazellularen bindung von zielgerichteten molekülen
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
NO972313D0 (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
AU669149B2 (en) Expression signal-peptide-free staphylokinases
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
IT1275909B1 (it) Frammento di dna codificante d-amminoacido ossidasi
DK0788549T3 (da) Regulerende nukleinsyresekvenser og anvendelser
KR940008700A (ko) 사람형 모노클로날 항펩티드 항체 및 이것을 코드하는 dna
DE69739263D1 (de) Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten
DK0778347T3 (da) Protein med formodede helicase- og ATPase-egenskaber, som binder ATP og nukleinsyre
WO2002074957A3 (en) Stress-responsive activator of p300 (strap) protein
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
ATE328088T1 (de) Transketolase-verwandtes protein
MX9709459A (es) Metodo para prolongar la expresion de un gen de interes usando moleculas de ctla4 solubles.